Papers matching “immune checkpoint inhibitors” 540
Not finding it? Sign in to also search OpenAlex live.
-
ESMO–ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors
Evert S.M. van Aken, Bharti Devnani, Arsela Prelaj, Luís Castelo-Branco, Corrie A.M. Marijnen, Diogo Alexandre Martins-Branco, +21 more
21citations -
Mass cytometry-based deep immune cell profiling of metastatic clear cell renal cell carcinoma patients refractory to combined immune checkpoint and tyrosine kinase inhibitor therapy.2025 Journal of Clinical Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Luigi Formisano, Stefania Belli, Angela Vallefuoco, Giovanna Pecoraro, Fortuna Migliaccio, Chiara Barraco, +7 more
0citations -
Correlative Monitoring of Immune Activation and Tissue Damage in Malignant Melanoma—An Algorithm for Identification of Tolerance Breakage During Immune Checkpoint Inhibitor Therapy of Cancer2020 International Journal of Molecular Sciences article Medicine Cancer Immunotherapy and Biomarkers Open access
Renate Ursula Wahl, Marike M. Leijs, Arturo Araujo, Albert Rübben
20citations -
Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence2024 International Journal of Molecular Sciences article Medicine Cancer Immunotherapy and Biomarkers Open access
Abdulaziz M. Eshaq, Thomas Wayne Flanagan, Abdulqader Ali Ba Abbad, Zain Alabden A. Makarem, Mohammed S. Bokir, Ahmed Khaled Alasheq, +8 more
20citations -
Associations between spatial distribution of immune cell subsets and clinical outcomes in patients with advanced melanoma treated with immune checkpoint inhibitors: results from the PUMA challenge
Mark Schuiveling, Hong Liu, Daniel Eek, Martina Hanusová, Isabella A.J. van Duin, Laurens S. ter Maat, +30 more
0citations -
Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy2021 Frontiers in Oncology article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent
Sven Heiko Loosen, Joao Gorgulho, Markus Sebastian Jördens, Maximilian Franz Schulze-Hagen, Fabian Beier, Mihael Vucur, +9 more
16citations -
Treatment patterns and survival outcomes of patients admitted to the intensive care unit due to immune‐related adverse events of immune checkpoint inhibitors
Lishi Lin, Aletta P. I. Houwink, Jolanda M. van Dieren, Esther K. Wolthuis, Johannes V. van Thienen, Michiel S. van der Heijden, +3 more
12citations -
Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections2023 Cancer Immunology Immunotherapy article Medicine Cancer Immunotherapy and Biomarkers Open access
Christina R. Schmitt, Esmée P. Hoefsmit, Nora Kramer, Canan Kabakci, Judith M. Versluis, Annette Compter, +10 more
8citations -
Associations between spatial distribution of immune cell subsets and clinical outcomes in patients with advanced melanoma treated with immune checkpoint inhibitors: results from the PUMA challenge
Mark Schuiveling, Hong Liu, Daniel Eek, Martina Hanusová, Isabella A.J. van Duin, Laurens S. ter Maat, +32 more
0citations -
Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem2021 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access
Kikkie Poels, Suzanne I.M. Neppelenbroek, Marie José Kersten, M. Louisa Antoni, Esther Lutgens, Tom T. P. Seijkens
61citations -
Serum levels of soluble B and T lymphocyte attenuator predict overall survival in patients undergoing immune checkpoint inhibitor therapy for solid malignancies2021 International Journal of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access
Joao Gorgulho, Christoph Roderburg, Felix Heymann, Maximilian Franz Schulze-Hagen, Fabian Beier, Mihael Vucur, +6 more
33citations -
Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single-institutional cohort study2023 Journal of the American Academy of Dermatology article Medicine Cutaneous Melanoma Detection and Management Open access
Nikolaus Benjamin Wagner, Sarah M. Knierim, Felix Luttermann, Gisela Metzler, Amir Sadegh Yazdi, Jürgen M. Bauer, +8 more
11citations